Because hydroxychloroquine is a well-established and safe treatment for autoimmune diseases such as rheumatoid arthritis where GM-CSF plays a pivotal role, it is possible that this drug could be repurposed to reduce the risk of RHD after ARF (77). The gene discussed is CSF2; the disease is rheumatoid arthritis.